Benhamou Y - Search Results

1

Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.

Lau G, Benhamou Y, Chen G, Li J, Shao Q, Ji D, Li F, Li B, Liu J, Hou J, Sun J, Wang C, Chen J, Wu V, Wong A, Wong CL, Tsang ST, Wang Y, Bassit L, Tao S, Jiang Y, Hsiao HM, Ke R, Perelson AS, Schinazi RF. Lau G, et al. Among authors: benhamou y. Lancet Gastroenterol Hepatol. 2016 Oct;1(2):97-104. doi: 10.1016/S2468-1253(16)30015-2. Epub 2016 Jul 25. Lancet Gastroenterol Hepatol. 2016. PMID: 27917405 Free PMC article. Clinical Trial.

2

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.

Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, Messous D, Charlotte F, Di Martino V, Benhamou Y, Poynard T. Myers RP, et al. Among authors: benhamou y. J Hepatol. 2003 Aug;39(2):222-30. doi: 10.1016/s0168-8278(03)00171-5. J Hepatol. 2003. PMID: 12873819

3

Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B.

Thabut D, Thibault V, Bernard-Chabert B, Mouquet C, Di Martino V, Le Calvez S, Opolon P, Benhamou Y, Bitker MO, Poynard T. Thabut D, et al. Among authors: benhamou y. Eur J Gastroenterol Hepatol. 2004 Nov;16(12):1367-73. doi: 10.1097/00042737-200412000-00022. Eur J Gastroenterol Hepatol. 2004. PMID: 15618847

4

Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1.

Benhamou Y, Thibault V, Vig P, Calvez V, Marcelin AG, Fievet MH, Currie G, Chang CG, Biao L, Xiong S, Brosgart C, Poynard T. Benhamou Y, et al. J Hepatol. 2006 Jan;44(1):62-7. doi: 10.1016/j.jhep.2005.08.020. Epub 2005 Sep 23. J Hepatol. 2006. PMID: 16274835

5

Treatment algorithm for chronic hepatitis B in HIV-infected patients.

Benhamou Y. Benhamou Y. J Hepatol. 2006;44(1 Suppl):S90-4. doi: 10.1016/j.jhep.2005.11.019. Epub 2005 Nov 28. J Hepatol. 2006. PMID: 16352368 Review.

6

Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.

Ingiliz P, Valantin MA, Thibault V, Duvivier C, Dominguez S, Katlama C, Poynard T, Benhamou Y. Ingiliz P, et al. Among authors: benhamou y. Antivir Ther. 2008;13(7):895-900. Antivir Ther. 2008. PMID: 19043923 Clinical Trial.

7

A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results.

Benhamou Y, Afdhal NH, Nelson DR, Shiffman ML, Halliman DG, Heise J, Chun E, Pockros PJ. Benhamou Y, et al. Hepatology. 2009 Sep;50(3):717-26. doi: 10.1002/hep.23073. Hepatology. 2009. PMID: 19585653 Clinical Trial.

8

Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection.

Manns MP, Bourlière M, Benhamou Y, Pol S, Bonacini M, Trepo C, Wright D, Berg T, Calleja JL, White PW, Stern JO, Steinmann G, Yong CL, Kukolj G, Scherer J, Boecher WO. Manns MP, et al. Among authors: benhamou y. J Hepatol. 2011 Jun;54(6):1114-22. doi: 10.1016/j.jhep.2010.08.040. Epub 2010 Nov 11. J Hepatol. 2011. PMID: 21145839 Clinical Trial.

9

Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: a retrospective repeated liver biopsy analysis.

Ingiliz P, Valantin MA, Preziosi P, Finzi L, Pais R, Fedchuk L, Dominguez S, Katlama C, Poynard T, Benhamou Y. Ingiliz P, et al. Among authors: benhamou y. J Hepatol. 2012 Jan;56(1):49-54. doi: 10.1016/j.jhep.2011.05.028. Epub 2011 Jul 23. J Hepatol. 2012. PMID: 21781946

10

Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C.

Poynard T, Moussalli J, Munteanu M, Thabut D, Lebray P, Rudler M, Ngo Y, Thibault V, Mkada H, Charlotte F, Bismut FI, Deckmyn O, Benhamou Y, Valantin MA, Ratziu V, Katlama C; FibroFrance-GHPS group. Poynard T, et al. Among authors: benhamou y. J Hepatol. 2013 Oct;59(4):675-83. doi: 10.1016/j.jhep.2013.05.015. Epub 2013 May 24. J Hepatol. 2013. PMID: 23712051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

360 results

Search Page